A new study reveals the rising burden of liver cancer, highlighting the significant impact of metabolic risk factors like obesity, in addition to viral hepatitis.

Rising obesity is a worldwide problem, but it's happening particularly rapidly in China, outpacing even wealthy nations. "Close to 70 per cent of the US population are overweight. But soon China ...

This development has become especially prominent in China, where new research reveals a sharp rise in cancer cases linked to obesity within this age group. As lifestyles evolve and obesity rates ...

Obesity increases risks from Covid-19 ... and have an unhealthy work schedule". China is not the only country to have seen an increase in the number of overweight or obese people in recent ...

More than 180 million people live with obesity in China, which has a population of 1.4 billion. According to Chinese business news website Yicai, a dose of four Wegovy injections will cost 1,400 ...

Liver cancer is a leading cause of cancer-related deaths worldwide, with distinct geographic patterns in its incidence.

The Series A funding round by the start-up, co-founded by executives of Aiolos Bio, the biotech that was sold to GSK last ...

The company had previously said it is focused on second- and third-generation opportunities in the space, such as oral versions as well as those with the potential to treat obesity-related conditions.

Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles high rates of obesity. The Danish ...

Medications known as glucagon-like peptide-1 agonists, or GLP-1s, have become very popular as weight loss agents. Taken in accordance with the instructions on the label and an appropriate diet and ...